A federal judge raised the prospect of not approving CVS Health’s deal to buy insurer Aetna, which closed earlier this week, during a routine portion of the legal process. Judge Richard Leon of the US District Court for the District of Columbia objected to what he said was the government’s and companies’ treatment of […]
According to Bloomberg, CVS has dodged one hurdle in its bid to buy insurer Aetna, as US antitrust enforcers don’t see competitive problems that could stem from uniting companies that operate at different levels of a supply chain. The investigation by the Justice Department’s antitrust division hasn’t turned up vertical- competition concerns from the merger, […]
The American Antitrust Institute (AAI) sent a letter to the US Department of Justice on Monday, March 26, urging the agency to block CVS’ planned purchase of Aetna, saying the deal would result in higher prices and lower quality in the prescription drug and health insurance markets. The AAI wrote to express concern that the […]
Shearman & Sterling is advising CVS on its US$69 billion acquisition of Aetna. This industry-transforming transaction is expected to provide more integrated and efficient healthcare services for consumers and health professionals. Under the terms of the agreement, Aetna shareholders will receive US$207 per share, comprising US$145 in cash and US$62 in CVS stock. Including the […]
Posted by Bloomberg CVS-Aetna Deal May Hinge on Antitrust Approach Under Trump By Robert Langreth, David McLaughlin & Zachary Tracer CVS Health’s US$67.5 billion takeover of Aetna will test the Trump administration’s approach to far-reaching corporate takeovers, just weeks after the US government sued to block a major telecommunications merger. The health-care deal unveiled Sunday would […]